SEC 13F Intelligence

Two Sigma Advisers, LP / CELG

Two Sigma Advisers, LP’s Celgene Corp Position

Does Two Sigma Advisers, LP own Celgene Corp (CELG)? Not currently — the last reported position was 644.7K shares worth $64M in Q3 2019; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$64M
Q3 2019
Shares
644.7K
% of Portfolio
+0.16%
Quarters Held
4
position exited

Position History CELG

Reported value by quarter
Q4 ’18: $207MQ4 ’18Q1 ’19: $251MQ1 ’19Q2 ’19: $154MQ2 ’19Q3 ’19: $64MQ3 ’19filingsflow.com
QuarterSharesValue% of Portfolio
Q3 2019644.7K$64M+0.16%
Q2 20191.66M$154M+0.38%
Q1 20192.66M$251M+0.63%
Q4 20183.23M$207M+0.56%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Two Sigma Advisers, LP’s full portfolio or all institutional holders of CELG.